David J. Maloney
Fundador en Veralox Therapeutics, Inc. .
Perfil
David J.
Maloney is the founder of Veralox Therapeutics, Inc. (founded in 2017) where he holds the title of Chief Scientific Officer.
In 2017, he worked as Vice President & Head-Translational Medicine at Rebus Holdings, Inc. Dr. Maloney holds a doctorate from the University of Virginia and an undergraduate degree from the University of Vermont.
Cargos activos de David J. Maloney
| Empresas | Cargo | Inicio |
|---|---|---|
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Fundador | 01/01/2017 |
Antiguos cargos conocidos de David J. Maloney.
| Empresas | Cargo | Fin |
|---|---|---|
| REBUS HOLDINGS, INC. | Corporate Officer/Principal | 01/12/2017 |
Formación de David J. Maloney.
| University of Virginia | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
- Bolsa de valores
- Insiders
- David J. Maloney
